Continuous Glucose Monitoring System
CGM system is Continuous Glucose Monitoring system. It essentially measures glucose levels 24/7, every few minutes, through a tiny sensor. This measures your interstitial glucose level, which is the glucose level found in the fluid between the cells.
What is CGM?
CGM is a Continuous Glucose Monitoring system. It essentially measures glucose levels 24/7, every few minutes, through a tiny sensor. This measures your interstitial glucose level, which is the glucose level found in the fluid between the cells.
Is CGM for me?
CGM is especially beneficial for people who1:
Have frequent low glucose levels
Want to reduce HbA1c without increasing hypoglycaemia
Experience fluctuating blood glucose levels
Can you tell which city this is?
If you can’t see the full picture,
it can be difficult to make informed decisions. It's the same with your glucose levels.
What are the Benefits of CGM?
A CGM system gives you a greater view of your glucose trend
more users reached HbA1c level <7.5%2
time spent in range3
*compared to MDI SMBG (multiple daily injection & self monitoring blood glucose)
What are the different ways to use CGM?
Whether you manage your diabetes with a pump, multiple daily injections, oral medications or through diet and exercise, Medtronic offers CGM products and insulin pump systems that give you, your loved ones and healthcare professionals the insights to track and manage your diabetes on your terms.
Always by your side
We know changing therapy can be daunting at first. Don’t worry, we are here to help you every step of the way.
Whatever you are facing we are always by your side, but not just through creating innovative products. It is also by helping you on your diabetes journey.
With 24/7 online resources and easy to access specialists, we want to empower you with more confidence and comfort in the management of your diabetes therapy.
Know that you are not alone. Know WeCare.
- Rodbard D. DIABETES TECHNOLOGY & THERAPEUTICS 2017;19(3):S25-S37
- Beck RW. et al. JAMA 2017;317(4):371-378.
- Ruedy KJ. et al. J Diabetes Sci Technol. 2017;11(6):1138-1146